» Articles » PMID: 28777835

Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy

Overview
Specialty Ophthalmology
Date 2017 Aug 5
PMID 28777835
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to develop a method for isolating, culturing, and characterizing cells from patient-derived membranes in proliferative vitreoretinopathy (PVR) to be used for drug testing.

Methods: PVR membranes were obtained from six patients with grade C PVR. Membrane fragments were analyzed by gross evaluation, fixed for immunohistologic studies to establish cell identity, or digested with collagenase II to obtain single cell suspensions for culture. PVR-derived primary cultures were used to examine the effects of methotrexate (MTX) on proliferation, migration, and cell death.

Results: Gross analysis of PVR membranes showed presence of pigmented cells, indicative of retinal pigment epithelial cells. Immunohistochemistry identified cells expressing α-smooth muscle actin, glial fibrillary acidic protein, Bestrophin-1, and F4/80, suggesting the presence of multiple cell types in PVR. Robust PVR primary cultures (C-PVR) were successfully obtained from human membranes, and these cells retained the expression of cell identity markers in culture. C-PVR cultures formed membranes and band-like structures in culture reminiscent of the human condition. MTX significantly reduced the proliferation and band formation of C-PVR, whereas it had no significant effect on cell migration. MTX also induced regulated cell death within C-PVR as assessed by increased expression of caspase-3/7.

Conclusions: PVR cells obtained from human membranes can be successfully isolated, cultured, and profiled in vitro. Using these primary cultures, we identified MTX as capable of significantly reducing growth and inducing cell death of PVR cells in vitro.

Citing Articles

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).

PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.


The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and Immunohistochemical study.

Attarbashee R, Hamodat H, Mammdoh J, Ridha-Salman H Toxicol Res (Camb). 2025; 14(1):tfaf007.

PMID: 39830884 PMC: 11739806. DOI: 10.1093/toxres/tfaf007.


Efficacy and safety of methotrexate in the treatment of proliferative vitreoretinopathy: a systematic review.

Toh V, Gerard G, Tay Z, Chen J, Chew G, Teoh C Eye (Lond). 2024; 39(3):460-467.

PMID: 39674839 PMC: 11794566. DOI: 10.1038/s41433-024-03503-5.


Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial.

Nourinia R, Safi S, Mohammadpour M, Riazi-Esfahani H, Ansari Astaneh M, Falavarjani K Sci Rep. 2024; 14(1):28842.

PMID: 39572739 PMC: 11582663. DOI: 10.1038/s41598-024-79708-1.


Proliferative Vitreoretinopathy: Pathophysiology and Therapeutic Approaches.

Lin J, Wu F, Kim L Int Ophthalmol Clin. 2024; 64(2):125-135.

PMID: 38525986 PMC: 10965228. DOI: 10.1097/IIO.0000000000000495.


References
1.
Wong L, Lee N, Amarnani D, Choi C, Bielenberg D, Freitag S . Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation. Ophthalmology. 2016; 123(9):2028-36. PMC: 5536972. DOI: 10.1016/j.ophtha.2016.05.052. View

2.
Kirchhof B, Sorgente N . Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev Ophthalmol. 1989; 16:1-53. View

3.
Hou H, Huffman K, Rios S, Freeman W, Sailor M, Cheng L . A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics. Invest Ophthalmol Vis Sci. 2015; 56(4):2755-63. PMC: 4416660. DOI: 10.1167/iovs.15-16526. View

4.
Gerards A, de Lathouder S, de Groot E, Dijkmans B, Aarden L . Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology (Oxford). 2003; 42(10):1189-96. DOI: 10.1093/rheumatology/keg323. View

5.
Khawly J, Saloupis P, Hatchell D, MACHEMER R . Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1991; 229(5):464-7. DOI: 10.1007/BF00166311. View